scispace - formally typeset
J

Jin-Soo Kim

Researcher at Seoul National University

Publications -  308
Citations -  26566

Jin-Soo Kim is an academic researcher from Seoul National University. The author has contributed to research in topics: CRISPR & Genome editing. The author has an hindex of 66, co-authored 264 publications receiving 21375 citations. Previous affiliations of Jin-Soo Kim include UPRRP College of Natural Sciences & Korea University of Science and Technology.

Papers
More filters
Journal ArticleDOI

Fabrication of a Touch Sensor for Flat Panel Displays Using Poly(3,4-ethylenedioxythiophene):Poly(styrene sulfonate) with Dimethylsulfoxide by Soft Lithography

TL;DR: In this paper, a transparent conductive polymers (PEDOT:PSS) was used as the conductive material, and the secondary dopant dimethyl sulfoxide (DMSO) is used to increase the conductivity.
Journal ArticleDOI

Utilizing Subpage Programming to Prolong the Lifetime of Embedded NAND Flash-Based Storage

TL;DR: This paper utilizes the subpage programming (SP) technique to decrease the amount of FTL metadata written to the nand flash memory and proposes a novel FTL called subpage FTL based on the SP technique to prolong the lifetime of embedded nandflash-based storage.
Journal ArticleDOI

The Anconeus Muscle Free Flap: Clinical Application to Lesions on the Hand.

TL;DR: The anconeus muscle free flap can be considered a reliable reconstructive option for small defects on the hand or contracture release of the web space, because it has relatively consistent anatomy, provides robust blood supply within the same operative field, and leads to no functional loss at the donor site.
Journal ArticleDOI

Partial second toe pulp free flaps in early childhood

TL;DR: Partial second toe pulp free flaps are an excellent option for fingertip reconstruction in young children, as well as in adults.
Journal ArticleDOI

Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the CANDOR study

TL;DR: The efficacy of KdD in RRMM treatment, including in patients with high‐risk cytogenetics, supports the efficacy of carfilzomib with dexamethasone in RR MM treatment, according to this CANDOR subgroup analysis.